Biomerica, Inc. Stock price
Is Biomerica, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.
Key metrics
Biomerica, Inc. Stock Analysis
Analyst Opinions
7 Analysts have issued a Biomerica, Inc. forecast:
Analyst Opinions
7 Analysts have issued a Biomerica, Inc. forecast:
Don't miss a Thing! We will send you all news about Biomerica, Inc. directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Biomerica, Inc. Stock News
Company Profile
Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. It focuses on gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates through the following geographical segments: Europe, United States, Asia, South America, Middle East, and Other Foreign. The company was founded in September 1971 and is headquartered in Irvine, CA.
| Head office | United States |
| CEO | Mr. Irani |
| Employees | 54 |
| Founded | 1971 |
| Website | biomerica.com |


